Merck Congratulates Guatemala as Fourth Country in Latin America to Achieve WHO Verification of Elimination of River Blindness
Dateline City:
KENILWORTH, N.J.KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada,
commends the government of Guatemala on being the fourth country in
Latin America to receive World Health Organization (WHO) verification of
the elimination of river blindness (onchocerciasis).Language:
EnglishContact: MerckLainie Keller, 908-236-5036Ticker Slug:Ticker:MRKExchange:NYSEread more (Source: Merck)
Source: Merck - September 29, 2016 Category: Pharmaceuticals Tags: Corporate Responsibility News Latest News Source Type: news
MSD Animal Health Receives Marketing Approval from European Medicines Agency for BRAVECTO™ (fluralaner) Spot-On Solution for Cats and Dogs
Dateline City:
MADISON, N.J.
Spot-On Treatment for Fleas and Ticks Effective For 12 Weeks
MADISON, N.J.--(BUSINESS WIRE)--MSD Animal Health (known as Merck Animal Health in the United States and
Canada) today announced that, following a positive opinion from the
Committee for Medicinal Products for Veterinary Use (CVMP), the European
Medicine Agency has granted a marketing authorization for the veterinary
medicinal product BRAVECTO™ (fluralaner) Spot-On Solution for bo...
Source: Merck - May 24, 2016 Category: Pharmaceuticals Tags: Animal Health #MSD $MRK Bravecto MSD Animal Health Source Type: news
New Pet Diabetes Tracker from Merck Animal Health Helps Owners of Diabetic Pets Manage the Disease
Dateline City:
MADISON, N.J.
Pet owners can monitor everything from food consumption to blood glucose
MADISON, N.J. – Merck Animal Health (known as MSD Animal Health outside the United States and Canada) today announced the launch of the Pet Diabetes Tracker, a free app that helps pet owners manage their pet’s diabetes on their smartphone or tablet.
Language:
English
read more (Source: Merck)
Source: Merck - February 11, 2016 Category: Pharmaceuticals Tags: Animal Health Latest News Source Type: news
Amgen and Merck Announce Cancer Immunotherapy Collaboration for Patients with Non-Hodgkin Lymphoma
Dateline City:
THOUSAND OAKS, Calif. and KENILWORTH, N.J.
Collaboration Includes Additional Select Advanced Solid Tumors
THOUSAND OAKS, Calif. and KENILWORTH, N.J. – Amgen (NASDAQ:AMGN) and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced a cancer immunotherapy collaboration to support a Phase 1b/3 study investigating BLINCYTO® (blinatumomab) in combination with KEYTRUDA® (pembrolizumab) in patients with diffuse large B-cell lymphoma (DLBCL), which is the most common ty...
Source: Merck - December 4, 2015 Category: Pharmaceuticals Source Type: news
Feature Story: Reporting on Our Progress
273 million lives impacted. $8.5 billion research and development expense. 210,500 hours volunteered. $1.3 billion donated. The 2011 Corporate Responsibility Report details our progress. (Source: Merck.com - Feature Stories About Merck)
Source: Merck.com - Feature Stories About Merck - February 15, 2013 Category: Pharmaceuticals Source Type: news
Feature Story: Staying the Course Against Infectious Disease
(Source: Merck.com - Feature Stories About Merck)
Source: Merck.com - Feature Stories About Merck - February 15, 2013 Category: Pharmaceuticals Source Type: news
Feature Story: Empowering People Who Live With HIV
Acclaimed photographer Duane Cramer joins I Design national HIV education campaign. (Source: Merck.com - Feature Stories About Merck)
Source: Merck.com - Feature Stories About Merck - February 6, 2013 Category: Pharmaceuticals Source Type: news
Feature Story: Why Animal Health Matters
Whether you have two legs, four legs, wings, tail or fins, health issues arise. Merck is committed to addressing unmet medical needs in both humans and animals. (Source: Merck.com - Feature Stories About Merck)
Source: Merck.com - Feature Stories About Merck - January 31, 2013 Category: Pharmaceuticals Source Type: news
Feature Story: Go Red For Women
Are you at risk for heart disease? It's the number one killer of women, yet only one in five American women believes that heart disease is their greatest threat. (Source: Merck.com - Feature Stories About Merck)
Source: Merck.com - Feature Stories About Merck - January 31, 2013 Category: Pharmaceuticals Source Type: news
Feature Story: In Focus: Alzheimer's Disease
Experts discuss the impact of Alzheimer's disease – on patients, caregivers and society – and opportunities for addressing the disease. (Source: Merck.com - Feature Stories About Merck)
Source: Merck.com - Feature Stories About Merck - January 10, 2013 Category: Pharmaceuticals Source Type: news
Feature Story: The Global Fight Against HIV/AIDS
Merck's Fight Against HIV/AIDS Focuses on Research, Access and Partnership. (Source: Merck.com - Feature Stories About Merck)
Source: Merck.com - Feature Stories About Merck - December 19, 2012 Category: Pharmaceuticals Source Type: news
Feature Story: World AIDS day
A memorial quilt. A commemorative dress. And, a renewed commitment. (Source: Merck.com - Feature Stories About Merck)
Source: Merck.com - Feature Stories About Merck - November 29, 2012 Category: Pharmaceuticals Source Type: news
Feature Story: A Growing Public Health Challenge
Know the risk factors for diabetes and take steps to protect your family's future. (Source: Merck.com - Feature Stories About Merck)
Source: Merck.com - Feature Stories About Merck - November 6, 2012 Category: Pharmaceuticals Source Type: news
Feature Story: Once Upon A Birth
Merck is working to help make sure every birth story has a happy ending. (Source: Merck.com - Feature Stories About Merck)
Source: Merck.com - Feature Stories About Merck - October 29, 2012 Category: Pharmaceuticals Source Type: news
Feature Story: Moments that matter
They were friends, teammates and champions together when the NY Mets won the World Series in 1986. Today, former Mets pitcher Ron Darling is championing a new cause to honor the memory of Gary Carter, who recently lost his battle with cancer. (Source: Merck.com - Feature Stories About Merck)
Source: Merck.com - Feature Stories About Merck - October 23, 2012 Category: Pharmaceuticals Source Type: news
